Cargando…
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
Purpose: COX-2 overexpression and elevated levels of prostaglandin E2 (PGE2) play an important role in breast cancer carcinogenesis. Recently, expression of the PGE2 receptor EP3 has been shown to be a positive prognostic factor in breast cancer. This study analyzes the functional aspects of targeti...
Autores principales: | Hester, Anna, Salzmann, Barbara, Rahmeh, Martina, Kolben, Thomas, Czogalla, Bastian, Ditsch, Nina, Mahner, Sven, Jeschke, Udo, Kolben, Theresa Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680222/ https://www.ncbi.nlm.nih.gov/pubmed/31534346 http://dx.doi.org/10.2147/OTT.S204919 |
Ejemplares similares
-
First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021) -
EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
por: Zati Zehni, Alaleh, et al.
Publicado: (2020) -
The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020) -
Expression of H3K4me3 and H3K9ac in breast cancer
por: Berger, Luisa, et al.
Publicado: (2020) -
High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)